Review article: Diagnosis of coeliac disease: a perspective on current and future approaches

Diagnostics will play a central role in addressing the ongoing dramatic rise in global prevalence of coeliac disease, and in deploying new non-dietary therapeutics. Clearer understanding of the immunopathogenesis of coeliac disease and the utility of serology has led to partial acceptance of non-biopsy diagnosis in selected cases. Non-biopsy diagnosis may expand further because research methods for measuring gluten-specific CD4+ T cells and the acute recall response to gluten ingestion in patients is now relatively straightforward. This perspective on diagnosis in the context of the immunopathogenesis of coeliac disease sets out to highlight current consensus, limitations of current practices, gluten food challenge for diagnosis and the potential for diagnostics that measure the underlying cause for coeliac disease, gluten-specific immunity.

Automated summary

Diagnostics are crucial in addressing the global prevalence of coeliac disease and promoting new non-dietary treatments. Non-biopsy diagnosis is gaining acceptance due to the better understanding of the immunopathogenesis of coeliac disease and the use of serology. Research methods for measuring gluten-specific CD4+ T cells and the acute recall response to gluten ingestion may further expand non-biopsy diagnosis.